Concepts (183)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Sepsis | 14 | 2024 | 2585 | 2.650 |
Why?
|
Shock, Septic | 7 | 2024 | 768 | 2.230 |
Why?
|
Renin-Angiotensin System | 7 | 2024 | 737 | 1.310 |
Why?
|
Resuscitation | 3 | 2019 | 673 | 1.270 |
Why?
|
Angiotensin II | 4 | 2024 | 849 | 1.030 |
Why?
|
Hypotension | 3 | 2018 | 879 | 0.890 |
Why?
|
Intensive Care Units | 5 | 2020 | 3744 | 0.890 |
Why?
|
Shock | 2 | 2024 | 314 | 0.820 |
Why?
|
Hospital Mortality | 7 | 2023 | 5293 | 0.710 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 2 | 2024 | 1516 | 0.680 |
Why?
|
Endothelium | 1 | 2022 | 765 | 0.650 |
Why?
|
Pulmonary Alveoli | 1 | 2022 | 652 | 0.650 |
Why?
|
Critical Illness | 5 | 2021 | 2723 | 0.650 |
Why?
|
Myeloid Cells | 1 | 2022 | 823 | 0.580 |
Why?
|
Isotonic Solutions | 1 | 2017 | 117 | 0.570 |
Why?
|
Propofol | 1 | 2023 | 603 | 0.560 |
Why?
|
Critical Care | 2 | 2020 | 2697 | 0.550 |
Why?
|
Bacteremia | 2 | 2022 | 980 | 0.520 |
Why?
|
Interleukin-6 | 3 | 2024 | 3208 | 0.480 |
Why?
|
Hypertension | 4 | 2022 | 8540 | 0.470 |
Why?
|
Respiratory Tract Diseases | 1 | 2020 | 750 | 0.470 |
Why?
|
Acute Kidney Injury | 3 | 2024 | 1924 | 0.450 |
Why?
|
Guideline Adherence | 3 | 2023 | 2220 | 0.450 |
Why?
|
Multiple Organ Failure | 3 | 2022 | 387 | 0.450 |
Why?
|
Hypertrophy, Left Ventricular | 2 | 2016 | 851 | 0.440 |
Why?
|
Biological Products | 1 | 2022 | 914 | 0.430 |
Why?
|
Renin | 3 | 2024 | 641 | 0.410 |
Why?
|
Causality | 1 | 2019 | 1242 | 0.410 |
Why?
|
Fluid Therapy | 1 | 2016 | 579 | 0.400 |
Why?
|
Periodicals as Topic | 2 | 2020 | 1463 | 0.390 |
Why?
|
Systemic Inflammatory Response Syndrome | 1 | 2017 | 621 | 0.380 |
Why?
|
Propensity Score | 1 | 2019 | 1913 | 0.370 |
Why?
|
Receptor, Angiotensin, Type 1 | 2 | 2022 | 153 | 0.360 |
Why?
|
Norepinephrine | 2 | 2024 | 897 | 0.360 |
Why?
|
Emergency Service, Hospital | 3 | 2019 | 7879 | 0.340 |
Why?
|
Inpatients | 1 | 2019 | 2548 | 0.290 |
Why?
|
Angiotensin Receptor Antagonists | 2 | 2024 | 1039 | 0.270 |
Why?
|
Blood Pressure | 3 | 2023 | 8481 | 0.260 |
Why?
|
Thrombosis | 1 | 2020 | 2942 | 0.260 |
Why?
|
Anti-Bacterial Agents | 3 | 2023 | 7406 | 0.250 |
Why?
|
Hospitals | 1 | 2019 | 3883 | 0.250 |
Why?
|
Models, Statistical | 1 | 2020 | 5079 | 0.250 |
Why?
|
Renal Circulation | 1 | 2024 | 291 | 0.220 |
Why?
|
Cecum | 2 | 2024 | 233 | 0.220 |
Why?
|
Thiadiazoles | 1 | 2024 | 63 | 0.220 |
Why?
|
Respiration, Artificial | 3 | 2022 | 2630 | 0.220 |
Why?
|
Ligation | 2 | 2024 | 448 | 0.220 |
Why?
|
Humans | 34 | 2024 | 761596 | 0.220 |
Why?
|
Biomedical Research | 1 | 2019 | 3429 | 0.210 |
Why?
|
Punctures | 2 | 2024 | 366 | 0.210 |
Why?
|
Circadian Rhythm | 1 | 2014 | 2576 | 0.200 |
Why?
|
Adrenergic Agents | 1 | 2022 | 74 | 0.200 |
Why?
|
Blood Pressure Monitoring, Ambulatory | 2 | 2014 | 244 | 0.200 |
Why?
|
Losartan | 2 | 2020 | 265 | 0.200 |
Why?
|
Prevalence | 5 | 2019 | 15733 | 0.190 |
Why?
|
Angiotensins | 1 | 2022 | 143 | 0.190 |
Why?
|
Vital Signs | 1 | 2023 | 144 | 0.190 |
Why?
|
APACHE | 2 | 2020 | 267 | 0.190 |
Why?
|
Hospitalization | 2 | 2020 | 10721 | 0.190 |
Why?
|
Receptor, Angiotensin, Type 2 | 1 | 2020 | 60 | 0.180 |
Why?
|
Lisinopril | 1 | 2020 | 61 | 0.180 |
Why?
|
Prospective Studies | 7 | 2024 | 54423 | 0.180 |
Why?
|
Bone Wires | 1 | 2020 | 124 | 0.170 |
Why?
|
Length of Stay | 4 | 2017 | 6426 | 0.170 |
Why?
|
Vasopressins | 1 | 2021 | 351 | 0.170 |
Why?
|
Feedback | 1 | 2023 | 791 | 0.170 |
Why?
|
Anesthetics, Intravenous | 1 | 2023 | 395 | 0.170 |
Why?
|
Data Interpretation, Statistical | 2 | 2019 | 2691 | 0.160 |
Why?
|
Peptidyl-Dipeptidase A | 1 | 2020 | 362 | 0.160 |
Why?
|
Time Factors | 7 | 2020 | 39969 | 0.150 |
Why?
|
Cytokines | 2 | 2024 | 7396 | 0.140 |
Why?
|
Risk Assessment | 2 | 2019 | 23996 | 0.140 |
Why?
|
Adrenergic beta-Antagonists | 1 | 2022 | 1241 | 0.140 |
Why?
|
Aged | 10 | 2022 | 169310 | 0.130 |
Why?
|
Coronary Thrombosis | 1 | 2019 | 440 | 0.130 |
Why?
|
Soft Tissue Infections | 1 | 2017 | 168 | 0.130 |
Why?
|
Cost Savings | 2 | 2019 | 913 | 0.120 |
Why?
|
Prosthesis-Related Infections | 1 | 2020 | 487 | 0.120 |
Why?
|
Intubation, Intratracheal | 1 | 2023 | 1333 | 0.120 |
Why?
|
Syndrome | 1 | 2021 | 3267 | 0.120 |
Why?
|
Calcium Channel Blockers | 1 | 2017 | 694 | 0.110 |
Why?
|
Male | 15 | 2024 | 360846 | 0.110 |
Why?
|
Steroids | 1 | 2019 | 929 | 0.110 |
Why?
|
Interferon-gamma | 1 | 2022 | 3162 | 0.110 |
Why?
|
Aged, 80 and over | 5 | 2019 | 58984 | 0.100 |
Why?
|
Antihypertensive Agents | 1 | 2022 | 2024 | 0.100 |
Why?
|
Echocardiography | 2 | 2016 | 4989 | 0.100 |
Why?
|
Female | 14 | 2024 | 392705 | 0.100 |
Why?
|
Guidelines as Topic | 1 | 2019 | 1386 | 0.100 |
Why?
|
Staphylococcus aureus | 1 | 2020 | 1457 | 0.100 |
Why?
|
Reproducibility of Results | 3 | 2020 | 20100 | 0.100 |
Why?
|
Severity of Illness Index | 3 | 2020 | 15843 | 0.100 |
Why?
|
Pyridines | 1 | 2024 | 2875 | 0.100 |
Why?
|
Renal Insufficiency | 1 | 2017 | 809 | 0.100 |
Why?
|
Lactic Acid | 1 | 2017 | 1139 | 0.100 |
Why?
|
Staphylococcal Infections | 1 | 2020 | 1407 | 0.090 |
Why?
|
Clinical Protocols | 1 | 2017 | 1440 | 0.090 |
Why?
|
Heart Rate | 1 | 2023 | 4195 | 0.090 |
Why?
|
Urinary Tract Infections | 1 | 2017 | 802 | 0.090 |
Why?
|
Lymphocyte Activation | 1 | 2022 | 5485 | 0.090 |
Why?
|
Disease Models, Animal | 4 | 2024 | 18255 | 0.090 |
Why?
|
Organ Transplantation | 1 | 2020 | 1157 | 0.090 |
Why?
|
ROC Curve | 1 | 2018 | 3578 | 0.090 |
Why?
|
Patient Admission | 1 | 2017 | 1367 | 0.090 |
Why?
|
Decision Support Techniques | 1 | 2020 | 1998 | 0.090 |
Why?
|
Fever | 1 | 2017 | 1618 | 0.080 |
Why?
|
Mice, Inbred C57BL | 3 | 2024 | 22174 | 0.080 |
Why?
|
Drug Administration Schedule | 1 | 2017 | 4853 | 0.080 |
Why?
|
Intensive Care Units, Pediatric | 1 | 2016 | 1017 | 0.080 |
Why?
|
Heart Arrest | 1 | 2019 | 1514 | 0.080 |
Why?
|
Middle Aged | 7 | 2022 | 220921 | 0.080 |
Why?
|
Myocardial Ischemia | 1 | 2019 | 2113 | 0.080 |
Why?
|
Treatment Outcome | 4 | 2019 | 64685 | 0.070 |
Why?
|
Pilot Projects | 1 | 2021 | 8633 | 0.070 |
Why?
|
Mice | 4 | 2024 | 81539 | 0.070 |
Why?
|
Retrospective Studies | 6 | 2020 | 80647 | 0.070 |
Why?
|
Platelet Aggregation Inhibitors | 1 | 2019 | 2751 | 0.070 |
Why?
|
Healthcare Disparities | 1 | 2022 | 3358 | 0.070 |
Why?
|
Prognosis | 2 | 2020 | 29629 | 0.070 |
Why?
|
Consensus | 1 | 2016 | 3124 | 0.070 |
Why?
|
Acute Coronary Syndrome | 1 | 2019 | 2190 | 0.060 |
Why?
|
Animals | 6 | 2024 | 168475 | 0.060 |
Why?
|
Curriculum | 1 | 2018 | 3743 | 0.060 |
Why?
|
Comorbidity | 1 | 2019 | 10508 | 0.060 |
Why?
|
T-Lymphocytes | 1 | 2022 | 10194 | 0.060 |
Why?
|
Chemokine CCL3 | 1 | 2024 | 84 | 0.060 |
Why?
|
Inflammation | 2 | 2022 | 10774 | 0.060 |
Why?
|
Cholinergic Agents | 1 | 2024 | 96 | 0.060 |
Why?
|
Multivariate Analysis | 1 | 2017 | 12059 | 0.050 |
Why?
|
Survival Rate | 1 | 2017 | 12723 | 0.050 |
Why?
|
Case-Control Studies | 1 | 2020 | 22176 | 0.050 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3086 | 0.050 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3206 | 0.050 |
Why?
|
Risk Factors | 4 | 2019 | 74213 | 0.050 |
Why?
|
Logistic Models | 1 | 2017 | 13255 | 0.050 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2018 | 10212 | 0.050 |
Why?
|
Quality Improvement | 1 | 2017 | 3802 | 0.050 |
Why?
|
Endotoxins | 1 | 2024 | 520 | 0.050 |
Why?
|
Heart Ventricles | 1 | 2013 | 3807 | 0.050 |
Why?
|
Databases, Factual | 1 | 2017 | 7968 | 0.050 |
Why?
|
Child | 4 | 2024 | 80158 | 0.050 |
Why?
|
Granulocyte Colony-Stimulating Factor | 1 | 2024 | 629 | 0.050 |
Why?
|
United States | 3 | 2019 | 72340 | 0.050 |
Why?
|
Age Factors | 1 | 2017 | 18399 | 0.040 |
Why?
|
Bacterial Load | 1 | 2020 | 152 | 0.040 |
Why?
|
Pandemics | 1 | 2020 | 8656 | 0.040 |
Why?
|
Phenotype | 1 | 2018 | 16592 | 0.040 |
Why?
|
Practice Guidelines as Topic | 1 | 2017 | 7391 | 0.040 |
Why?
|
Adult | 3 | 2023 | 221210 | 0.040 |
Why?
|
Chemokines | 1 | 2024 | 959 | 0.040 |
Why?
|
Cohort Studies | 2 | 2024 | 41495 | 0.040 |
Why?
|
Child, Preschool | 3 | 2024 | 42232 | 0.040 |
Why?
|
Signal Transduction | 1 | 2022 | 23447 | 0.040 |
Why?
|
Postoperative Complications | 1 | 2020 | 15633 | 0.040 |
Why?
|
Angiotensin II Type 1 Receptor Blockers | 1 | 2020 | 431 | 0.040 |
Why?
|
Leukocyte Count | 1 | 2020 | 1596 | 0.030 |
Why?
|
Algorithms | 1 | 2017 | 14033 | 0.030 |
Why?
|
Biofilms | 1 | 2020 | 627 | 0.030 |
Why?
|
Follow-Up Studies | 2 | 2014 | 39106 | 0.030 |
Why?
|
Lipopolysaccharides | 1 | 2022 | 2206 | 0.030 |
Why?
|
Adolescent | 3 | 2024 | 88326 | 0.030 |
Why?
|
Heart Failure | 1 | 2017 | 11671 | 0.030 |
Why?
|
Lymphocytes | 1 | 2020 | 2612 | 0.030 |
Why?
|
Drug-Eluting Stents | 1 | 2019 | 681 | 0.030 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2024 | 4352 | 0.030 |
Why?
|
Europe | 1 | 2019 | 3420 | 0.020 |
Why?
|
Host-Pathogen Interactions | 1 | 2020 | 1459 | 0.020 |
Why?
|
Drug Costs | 1 | 2019 | 1183 | 0.020 |
Why?
|
Creatinine | 1 | 2016 | 1899 | 0.020 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2024 | 4580 | 0.020 |
Why?
|
Infant, Premature, Diseases | 1 | 2016 | 710 | 0.020 |
Why?
|
Kidney | 1 | 2024 | 7048 | 0.020 |
Why?
|
C-Reactive Protein | 1 | 2020 | 3826 | 0.020 |
Why?
|
Infant | 2 | 2024 | 36193 | 0.020 |
Why?
|
Neutrophils | 1 | 2020 | 3767 | 0.020 |
Why?
|
Young Adult | 1 | 2014 | 59260 | 0.020 |
Why?
|
Hemorrhage | 1 | 2019 | 3424 | 0.020 |
Why?
|
Infant, Premature | 1 | 2016 | 2107 | 0.020 |
Why?
|
Linear Models | 1 | 2016 | 5872 | 0.020 |
Why?
|
Cost-Benefit Analysis | 1 | 2019 | 5493 | 0.020 |
Why?
|
Registries | 1 | 2019 | 8225 | 0.010 |
Why?
|
Brain | 1 | 2024 | 27121 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2016 | 26202 | 0.010 |
Why?
|
Concepts
(183)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(16)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_